A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising

Bibliographic Details
Main Authors:	Paul Burton, MD, PhD, FACC, W. Frank Peacock, MD, FACEP
Format:	Article
Language:	English
Published:	Elsevier 2016-05-01
Series:	HeartRhythm Case Reports
Subjects:	Rivaroxaban Stroke Atrial fibrillation Legal advertising
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027116000142

Internet